CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.70
+0.00%Margins
Gross margin
53.2%
EBITDA margin
-13.1%
EBIT margin
-21.6%
Net margin
-39.0%
FCF margin
-5.8%
-25.0%
Return on equity
-18.0%
Return on assets
-12.8%
Return on invested capital
0.46x
Asset turnover
-$6.0M
Cash from operations
$2.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026